1.895EUR
23.87 MEUR
785.69 MEUR
5.40 M
About GUERBET
Sector
Industry
CEO
David Hale
Website
Headquarters
Paris
Employees (FY)
2.92 K
Founded
1968
ISIN
FR0000032526
FIGI
BBG000KF0X64
Guerbet SA engages in the research, development, manufacture, and sale of contrast products for medical imaging. The company operates through the following segments: Diagnostic Imaging and Interventional Imaging. The Diagnostic Imaging segment includes MRI and X-Ray contrast media. The Interventional Imaging covers any invasive medical procedure whose purpose is to diagnose and treat a disease. The company was founded by André Guerbet in 1926 and is headquartered in Paris, France.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange GUERBET S.A. stocks are traded under the ticker 4G8.
GUERBET S.A. revenue for the last quarter amounts to 371.05 M EUR despite the estimated figure of 371.10 M EUR. In the next quarter revenue is expected to reach 378.55 M EUR.
Yes, you can track GUERBET S.A. financials in yearly and quarterly reports right on TradingView.
4G8 net income for the last quarter is 21.78 M EUR, while the quarter before that showed 2.08 M EUR of net income which accounts for 945.25% change. Track more GUERBET S.A. financial stats to get the full picture.
Yes, 4G8 dividends are paid annually. The last dividend per share was 0.50 EUR. As of today, Dividend Yield (TTM)% is 1.39%. Tracking GUERBET S.A. dividends might help you take more informed decisions.
Like other stocks, 4G8 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GUERBET S.A. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 2.92 K employees. See our rating of the largest employees — is GUERBET S.A. on this list?
We've gathered analysts' opinions on GUERBET S.A. future price: according to them, 4G8 price has a max estimate of 42.70 EUR and a min estimate of 39.00 EUR. Read a more detailed GUERBET S.A. forecast: see what analysts think of GUERBET S.A. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GUERBET S.A. EBITDA is 97.77 M EUR, and current EBITDA margin is 11.91%. See more stats in GUERBET S.A. financial statements.